MCM6 and pachyonychia congenita: Elevated levels of MCM6 were notably linked to PC progression, aggressive PC cell behaviours, poorer disease‐free survival and poorer overall survival suggesting its significance as a prognostic marker, although it did not independently predict adverse outcomes in PC.42, 43